82_FR_61821 82 FR 61573 - Healthcare Infection Control Practices Advisory Committee (HICPAC)

82 FR 61573 - Healthcare Infection Control Practices Advisory Committee (HICPAC)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 248 (December 28, 2017)

Page Range61573-61574
FR Document2017-28072

In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This meeting is open to the public, limited only by audio phone lines available. The public is also welcome to listen to the meeting by dialing 888-946-7207, passcode: 5023213. A total of 200 lines will be available. To register for this call, please go to www.cdc.gov/hicpac.

Federal Register, Volume 82 Issue 248 (Thursday, December 28, 2017) 
[Federal Register Volume 82, Number 248 (Thursday, December 28, 2017)]
[Notices]
[Pages 61573-61574]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-28072]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Healthcare Infection Control 
Practices Advisory Committee (HICPAC). This meeting is open to the 
public, limited only by audio phone lines available. The public is also 
welcome to listen to the meeting by

[[Page 61574]]

dialing 888-946-7207, passcode: 5023213. A total of 200 lines will be 
available. To register for this call, please go to www.cdc.gov/hicpac.

DATES: The meeting will be held on February 15, 2018, 12:00 p.m. to 
2:00 p.m., EST.

ADDRESSES: Teleconference Number: 888-946-7207, passcode: 5023213

FOR FURTHER INFORMATION CONTACT: Erin Stone, M.A., HICPAC, Division of 
Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, 
Mailstop A-31, Atlanta, Georgia 30333; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health 
and Human Services regarding (1) the practice of healthcare infection 
prevention and control; (2) strategies for surveillance, prevention, 
and control of infections, antimicrobial resistance, and related events 
in settings where healthcare is provided; and (3) periodic updating of 
CDC guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters To Be Considered: The agenda will include discussions from 
the recommendation categorization update workgroup, the guidelines for 
infection prevention in healthcare personnel workgroup, and the 
guidelines for infection prevention in patients of neonatal intensive 
care units workgroup. Agenda items are subject to change as priorities 
dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2017-28072 Filed 12-27-17; 8:45 am]
 BILLING CODE 4163-19-P

Federal Register / Vol. 82, No. 248 / Thursday, December 28, 2017 / Notices 61573 DEPARTMENT OF HEALTH AND advance or enhance the social, physical, DEPARTMENT OF HEALTH AND HUMAN SERVICES and economic status of AI/ANs; and HUMAN SERVICES promoting health equity for all Indian Centers for Disease Control and people and communities. To advance Centers for Disease Control and Prevention these goals, CDC/ATSDR conducts Prevention government-to-government Office for State, Tribal, Local and Advisory Committee on Immunization consultations with elected tribal Practices (ACIP); Notice of Charter Territorial Support (OSTLTS), Tribal Advisory Committee (TAC) Meeting officials or their authorized Amendment and 18th Biannual Tribal Consultation representatives. Consultation is an enhanced form of communication that AGENCY: Centers for Disease Control and Session emphasizes trust, respect, and shared Prevention (CDC), Department of Health AGENCY: Centers for Disease Control and responsibility. It is an open and free and Human Services (HHS). Prevention (CDC), Department of Health exchange of information and opinion ACTION: Notice of charter amendment. and Human Services (HHS). among parties that leads to mutual ACTION: Notice of meeting. SUMMARY: This gives notice under (the understanding. Federal Advisory Committee Act of SUMMARY: The Centers for Disease Matters To Be Considered: The agenda October 6, 1972, that the Advisory Control and Prevention (CDC)/Agency will include discussions on tribal Committee on Immunization Practices for Toxic Substances and Disease priorities for the CDC and ATSDR, (ACIP), Centers for Disease Control and Registry (ATSDR), announces the public health capacity in Indian Prevention, Department of Health and following meeting and Tribal Country, AI/AN public health concerns, Human Services, has amended their Consultation Session. The meetings are budget and funding opportunities, and charter to include a non-voting liaison being hosted by CDC/ATSDR in-person programmatic highlights. Agenda items representative; American Immunization only and are open to the public. are subject to change as priorities Registry Association. The amended Attendees must pre-register for the dictate. filing date is October 17, 2017. event by March 2, 2018, at the following FOR FURTHER INFORMATION CONTACT: Tribal nations also will have an link: www.cdc.gov/tribal/meetings.html. Stephanie Thomas, ACIP Committee opportunity to present testimony about DATES: Management Specialist, CDC, NCIRD, tribal health issues. All tribal leaders are Email ACIP@cdc.gov. March 13, 2018 encouraged to submit written testimony The Director, Management Analysis • 8:00 a.m.–5:00 p.m., EDT—Tribal by 5:00 p.m. (EST) Friday, February 16, and Services Office, has been delegated Caucus (Open only to elected tribal 2018, to CDC’s Tribal Support Unit via the authority to sign Federal Register leaders and by invitation) mail to 4770 Buford Highway NE, MS notices pertaining to announcements of E–70, Atlanta, GA 30341–3717, or email meetings and other committee March 14, 2018 to TribalSupport@cdc.gov. Tribal management activities, for both the • 8:00 a.m.–5:00 p.m., EDT—TAC leaders can find guidance to assist in Centers for Disease Control and Meeting (Open to the public) developing tribal testimony for CDC and Prevention and the Agency for Toxic ADDRESSES: CDC, Global ATSDR at www.cdc.gov/tribal/ Substances and Disease Registry. Communications Center Auditorium B3, consultation/index.html. Claudette Grant, 1600 Clifton Road NE, Atlanta, Georgia Based on the number of tribal leaders Acting Director, Management Analysis and 30329. giving testimony and the time available, Services Office, Centers for Disease Control FOR FURTHER INFORMATION CONTACT: it may be necessary to limit the time for and Prevention. Carmen Clelland, PharmD, MPA, MPH, each. [FR Doc. 2017–28069 Filed 12–27–17; 8:45 am] Associate Director for Tribal Support, BILLING CODE 4163–18–P Office for State, Tribal, Local and The Director, Management Analysis Territorial Support, CDC, 4770 Buford and Services Office, has been delegated Highway, Mailstop E–70, Atlanta, GA the authority to sign Federal Register DEPARTMENT OF HEALTH AND 30341–3717; (404) 498–2205; notices pertaining to announcements of HUMAN SERVICES cclelland@cdc.gov. meetings and other committee SUPPLEMENTARY INFORMATION: This management activities, for both the Centers for Disease Control and meeting is being held in accordance Centers for Disease Control and Prevention with Presidential Executive Order No. Prevention, and the Agency for Toxic 13175, November 6, 2000, and the Substances and Disease Registry. Healthcare Infection Control Practices Presidential Memorandum of November Advisory Committee (HICPAC) Claudette Grant, 5, 2009, and September 23, 2004, AGENCY: Centers for Disease Control and Acting Director, Management Analysis and Consultation and Coordination with Prevention (CDC), Department of Health Services Office, Centers for Disease Control Indian Tribal Governments. and Human Services (HHS). and Prevention. Purpose: The purpose of the TAC and ACTION: Notice of meeting. [FR Doc. 2017–28071 Filed 12–27–17; 8:45 am] consultation meetings is to advance CDC/ATSDR support for and BILLING CODE 4160–18–P SUMMARY: In accordance with the collaboration with American Indian and Federal Advisory Committee Act, the sradovich on DSK3GMQ082PROD with NOTICES Alaska Native (AI/AN) tribes and to CDC announces the following meeting improve the health of AI/AN tribes by for the Healthcare Infection Control pursuing goals that include assisting in Practices Advisory Committee eliminating the health disparities faced (HICPAC). This meeting is open to the by AI/AN tribes; ensuring that access to public, limited only by audio phone critical health and human services and lines available. The public is also public health services is maximized to welcome to listen to the meeting by VerDate Sep<11>2014 18:14 Dec 27, 2017 Jkt 244001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\28DEN1.SGM 28DEN1

61574 Federal Register / Vol. 82, No. 248 / Thursday, December 28, 2017 / Notices dialing 888–946–7207, passcode: DEPARTMENT OF HEALTH AND effectiveness of intracranial aneurysm 5023213. A total of 200 lines will be HUMAN SERVICES treatment devices and factors that can available. To register for this call, please affect clinical outcomes such as go to www.cdc.gov/hicpac. Food and Drug Administration aneurysm morphology, size, and [Docket No. FDA–2017–N–6888] location in the neurovasculature. FDA is DATES: The meeting will be held on also convening this committee to seek February 15, 2018, 12:00 p.m. to 2:00 Neurological Devices Panel of the expert opinion on the scientific and p.m., EST. Medical Devices Advisory Committee; clinical considerations relating to the ADDRESSES:Teleconference Number: Notice of Meeting clinical trial design that may be relevant 888–946–7207, passcode: 5023213 to the determination of safety and AGENCY: Food and Drug Administration, effectiveness for these devices. FOR FURTHER INFORMATION CONTACT: Erin HHS. FDA intends to make background Stone, M.A., HICPAC, Division of ACTION: Notice. material available to the public no later Healthcare Quality Promotion, NCEZID, than 2 business days before the meeting. SUMMARY: The Food and Drug If FDA is unable to post the background CDC, 1600 Clifton Road NE, Mailstop Administration (FDA) announces a material on its website prior to the A–31, Atlanta, Georgia 30333; Email: forthcoming public advisory committee HICPAC@cdc.gov. meeting, the background material will meeting of the Neurological Devices be made publicly available at the SUPPLEMENTARY INFORMATION: Panel of the Medical Devices Advisory location of the advisory committee Purpose: The Committee is charged Committee. The general function of the meeting, and the background material committee is to provide advice and will be posted on FDA’s website after with providing advice and guidance to recommendations to the Agency on the meeting. Background material is the Director, Division of Healthcare FDA’s regulatory issues. The meeting available at https://www.fda.gov/ Quality Promotion (DHQP), the Director, will be open to the public. National Center for Emerging and AdvisoryCommittees/Calendar/ DATES: The meeting will be held on default.htm. Scroll down to the Zoonotic Infectious Diseases (NCEZID), March 1, 2018, from 8 a.m. to 6 p.m. appropriate advisory committee meeting the Director, CDC, the Secretary, Health ADDRESSES: Hilton Washington, DC link. and Human Services regarding (1) the North/Gaithersburg, 620 Perry Pkwy., Procedure: Interested persons may practice of healthcare infection present data, information, or views, Salons A, B, C, and D, Gaithersburg, MD prevention and control; (2) strategies for 20877. The hotel’s telephone number is orally or in writing, on issues pending surveillance, prevention, and control of 301–977–8900. Answers to commonly before the committee. Written infections, antimicrobial resistance, and asked questions including information submissions may be made to the contact related events in settings where regarding special accommodations due person on or before January 19, 2018. healthcare is provided; and (3) periodic to a disability, visitor parking, and Oral presentations from the public will updating of CDC guidelines and other transportation may be accessed at: be scheduled between approximately 1 policy statements regarding prevention https://www.fda.gov/Advisory p.m. and 2 p.m. Those individuals of healthcare-associated infections and Committees/AboutAdvisoryCommittees/ interested in making formal oral healthcare-related conditions. ucm408555.htm. presentations should notify the contact Matters To Be Considered: The agenda person and submit a brief statement of FOR FURTHER INFORMATION CONTACT: will include discussions from the the general nature of the evidence or Aden Asefa, Center for Devices and arguments they wish to present, the recommendation categorization update Radiological Health, Food and Drug names and addresses of proposed workgroup, the guidelines for infection Administration, 10903 New Hampshire participants, and an indication of the prevention in healthcare personnel Ave., Bldg. 66, Rm. G642, Silver Spring, approximate time requested to make workgroup, and the guidelines for MD 20993–0002, Aden.Asefa@ their presentation on or before January infection prevention in patients of fda.hhs.gov, 301–796–0400, or FDA 12, 2018. Time allotted for each neonatal intensive care units Advisory Committee Information Line, presentation may be limited. If the workgroup. Agenda items are subject to 1–800–741–8138 (301–443–0572 in the number of registrants requesting to change as priorities dictate. Washington, DC area). A notice in the speak is greater than can be reasonably Federal Register about last minute accommodated during the scheduled The Director, Management Analysis modifications that impact a previously and Services Office, has been delegated open public hearing session, FDA may announced advisory committee meeting conduct a lottery to determine the the authority to sign Federal Register cannot always be published quickly notices pertaining to announcements of speakers for the scheduled open public enough to provide timely notice. hearing session. The contact person will meetings and other committee Therefore, you should always check the management activities, for both the notify interested persons regarding their Agency’s website at https:// request to speak by January 16, 2018. Centers for Disease Control and www.fda.gov/AdvisoryCommittees/ Persons attending FDA’s advisory Prevention and the Agency for Toxic default.htm and scroll down to the committee meetings are advised that the Substances and Disease Registry. appropriate advisory committee meeting Agency is not responsible for providing link, or call the advisory committee access to electrical outlets. Claudette Grant, information line to learn about possible FDA welcomes the attendance of the Acting Director, Management Analysis and modifications before coming to the public at its advisory committee sradovich on DSK3GMQ082PROD with NOTICES Services Office, Centers for Disease Control meeting. meetings and will make every effort to and Prevention. [FR Doc. 2017–28072 Filed 12–27–17; 8:45 am] SUPPLEMENTARY INFORMATION: accommodate persons with disabilities. Agenda: On March 1, 2018, the If you require accommodations due to a BILLING CODE 4163–19–P committee will discuss, make disability, please contact AnnMarie recommendations, and advise FDA Williams at Annmarie.Williams@ regarding the evaluation of clinical fda.hhs.gov or 301–796–5966 at least 7 study data to support the safety and days in advance of the meeting. VerDate Sep<11>2014 18:14 Dec 27, 2017 Jkt 244001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\28DEN1.SGM 28DEN1


Document Created: 2017-12-28 00:43:21
Document Modified: 2017-12-28 00:43:21
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting.
DatesThe meeting will be held on February 15, 2018, 12:00 p.m. to 2:00 p.m., EST.
ContactErin Stone, M.A., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop A-31, Atlanta, Georgia 30333; Email: [email protected]
FR Citation82 FR 61573 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR